 |
AUTHORS:
Robert
H. Demling, M.D. Leslie
DeSanti R.N.,
Dennis P. Orgill, M.D. Ph.D.
REFERENCES
| SKIN
ANATOMY
Mast B: The Skin. In: Wound
Healing. Cohen K, Diegelmann I, editors, WB Saunders. Philadelphia
1992; 344-355.
BIOLOGICAL COMPONENTS (CELLS)
Wright N., Alison M: The
biology of epithelial cell populations. Clarendon press 1984; 283-345.
Stenn S., Malhotra R:
Epithelialization. In Wound Healing. C Cohen (ed) WB Saunders,
Philadelphia, PA 1992; 115-127.
Grillo H: Origin of
fibroblasts in wound healing. Annals of Surgery 1963;157:453-467.
Karasck M: Mechanism of
angiogenesis in normal and diseased skin. International Journal of
Dermatology 1991:30; 831-835.
Leibovich S, Ross R: The role
of the macrophage in wound repair. American Journal of Pathology 1975:
78;71-91.
BIOLOGICAL COMPONENTS
(MATRIX)
Raghow R: The role of
extracellular matrix in post inflammatory wound healing and fibrosis.
FASEB J 8:823-850, 1994.
Weigel P, Fuller G, LeBoeuf
R: The model for the role of hyaluronic acid and fibrin in the early
events during the inflammatory response and wound healing. J Theor
Biol 119: 219-234, 1986.
Alps L. Murray B, Rollins B:
Fibronectin and proteoglycans as determinants of cell-substration
adhesion. J Supramol Struc 1979:11; 401-427.
Wertzhandler M, Bernfield M:
Proteoglycan glycoconjugates. In Wound Healing C. Cohen (ed) WB
Saunders, Philadelphia, PA 1991, pg 195.
BIOLOGIC COMPONENTS (GROWTH
FACTORS AND ENHANCERS)
McGrath M: Peptide growth
factors and wound healing. Clin Plastic Surg 1991: 17; 421-428.
Yates R: Epidermal growth
factors and related growth factors. Int J Dermatol 1991: 30: 687-691.
Falanger V: Growth factors
and wound healing. J Dermatol 1993:19; 711-718.
Steenfas H: Growth factors
and wound healing. Scand J Plast Reconstruct Hand Surg 1994: 28;
95-102.
Peschel C, Houber C,
Aulitzsky W: Clinical application of cytokines. Press Med 1994:23;
1083-1090.
|
BIOLOGICAL
COMPONENTS (MATRIX PROTEINS) - COLLAGEN AND FIBRONECTIN
Madden J, Peacock E: Studies
on the biology of collagen during wound healing. Annals of Surgery
1971:174 (3): 511-520.
Clore J, Cohen I, Diegelmann
R: Quantitation of collagen types I and III during wound healing.
Proceedings of the Society for Experimental Biology and Medicine 1979:
161; 337-340.
Doillon C, Dunn M, Bender E,
et al: Collagen fiber formation in repair tissue: Development of
strength and toughness. Collagen and Related Research 1985: 5:481-485.
Takashima A, Grinnell F:
Human keratinocyte adhesion and phagocytosis. Prompted by fibronectin.
Journal of Investigatiive Dermatology 1984:83;352-358.
Clark R, Folkvard J, Wortz R:
Fibronectins, as well as other extracellular matrix proteins mediate
human keratinocyte adherence. Journal of Investigative Dermatology
1985:84; 378-383.
Posposilov J, Riebelov V:
Fibronectin-its significance in wound re-epithelialization. Acta
Chirurgiae Plasticae 1986:28; 96-102.
Guo M, Toda K, Grinnell F:
Activation of human keratinocyte migration on type I collagen and
fibronectin. Journal of Cell Science 1990:96; 197-205.
Donaldson D, Mahan J:
Fibrinogen and fibronectin as substrates for epidermal cell migration
during wound closure. Journal of Cell Science 1983:62; 117-127.
Grinnell F: Distribution of
fibronectin during wound healing in vivo. Journal of Investigative
Dermatology 1981: 76; 181-189.
Ehrlich. The role of
connective tissue matrix in wound healing. Prog Clin Biol Res 1988:
266; 243.
Miller E, Gay S. The
collagens: an overview. Methods Enzymol 1987: 144: 3.
Stenn K, Malhotia R.
Epithelialization in wound healing: biochemical and clinical aspects.
Cohen K, Editor, Saunders, Philadelphia 1992: p 115.
Miller E, Gay S, Collagen
structure and function in wound healing: biochemical and clinical
aspects. Cohen K, Editor, Saunders, Philadelphia 1992; p 130.
|
| WOUND
HEALING
Angiogenesis
Folkman J, Klagsburn M:
Angiogenic factors: Science 1987:235; 442-447.
Knighton D, Hunt T, Thakral K:
Role of platelets and fibrin and the healing sequences on in-vivo. Study
of angiogenesis and collagen synthesis. Ann Surg 1982: 196; 379-388.
Fibroblast
Proliferation
Morgan C, Pledger J: Fibroblast
proliferation. In: Wound Healing, C.Cohen (ed) WB Saunders, Philadelphia,
PA 1992, pg 63.
Epithelial
Proliferation
Yates R: Epidermal growth factors
and related growth factors. Int J Dermatol 1991: 30; 687-691.
Inoue M, Kratz G, et al:
Collagenase expression is rapidly induced in wound edge keratinocytes
after acute injury in human skin, Persists during healing and stops at re-epithelialization.
J Invest Dermatol 1995: 104; 479.
Mansliridge J, Knapp A: Changes
in keratinocyte maturation during wound healing. J Invest Dermatol 1987:
89: 253-263.
Grinnell F, Toda K, Takashima A:
Activation of keratinocyte fibronectin receptor during cutaneous wound
healing. J Cell Sci 1987: 8; 199-209.
Saariatho-Kere U, Kovacs, et al:
Cell-matrix interactions modulate interstitial collagenase expression by
human keratinocytes actively involved in wound healing. J Clin Invest
1995: 92; 2858.
Boulton L, Fattu A: Topical
agents and wound healing. Clin Dermatol 1994: 12; 95-100.
|
Collagen Synthesis
Bornstein P, Sage H: Structurally
distinct collagen types. Am Rev Biochem 1980: 49; 957-960.
Miller E, Gay S: Collagen: An
Overview. Methods Enzymol 1982: 82; 3.
BURN INJURY
Demling R. Pathophysiology of
burn injury. In: Trauma: clinical care and pathophysiology. J Richardson
(editor), Chicago, IL, 1987, p 128.
Neely A, Brown R, Chendening C,
et al: Proteolytic activity in human burn wounds. Wound Repair and
Regeneration 1997: 5; 302-9.
Young P, Grinnell F:
Metalloproteinase activation cascade after burn injury: Longitudinal
analysis of the human wound environment. Journal of Investigative
Dermatology 1994: 103; 660-664.
Zawacki B: Reversal of capillary
stasis and prevention of necrosis in burns. Annals of Surgery 1974: 180;
98-102.
BURN DEPTH - CONVERSION
Cotran R: The delayed and
prolonged vascular leakage in inflammation. American Journal of Pathology
1965: 46; 589-620.
Zawacki B: The natural history of
reversible burn injury. Surgery of Gynecology and Obstetrics 1974: 139;
867-872.
Jackson DM: The diagnosis of
depth of burning. British Journal of Surgery 1953: 40; 588-96.
DelBeccaro E, Robson M, Heggers
J, Swaminathan R: The use of specific thromboxane inhibitors to preserve
the dermal microcirculation after burning. Surgery 1980: 87; 137-141.
|
| LOCAL
HEALING PROBLEMS
Hohn D, Mackay R, Hunt T:
The effect of O2 Tension on the microbicidal function of leukocytes
in wounds. Surg Forum 1976: 27; 18-20.
Hinman C, Maibach H: Effect
of an exposure and occlusion on experimental human skin wounds.
Nature 1963: 200; 377-8.
Robson M, Heggers J:
Delayed wound closure based on bacterial counts. J Surg Oncol 1970:
2; 379-383.
Robson M: Burn sepsis. Crit
Care Clin 1988: 4; 281-298.
Lineaweaver H, Howard R,
Soucy D, et al: Topical antimicrobal toxicity. Arch Surg 1985: 120;
267-270.
WOUND DRESSINGS
Linsky C, Rovee D, Dow T:
Effect of dressings on wound inflammation and scar tissue. In the
Surgical Wound, Dineen P (ed). Philadelphia, PA 1981, 191-205.
Alverez O, Mertz P,
Eaglestein W: The effect of occlusive dressings on collagen
synthesis and epithelialization in superficial wounds. J Surg Res
1983: 35; 142-148.
De Riel S: Assessment of
burn wound therapy systems. In Burn Wound Coverage, W DeRiel, CRC
Press 1989, p 1-38.
Falagna V: Occlusive wound
dressings. Arch Dermatol 1988: 124; 872-877.
Wiseman D, Rovee D, Alvarez
O: Wound dressing: design and use. In: Wound Healing, C Cohen (ed)
WB Saunders, Philadelphia, PA 1992, p 562.
Winter G. Formation of scab
and the rate of epithelialization of superficial wounds in the skin.
Nature 1962: 193; 293-298.
Linsky C. Effect of
dressings on wound inflammation and scar tissue. In G Hildrith-Smith,
Editor. The Surgical Wound, Philadelphia, Lea and Febizer 1981, p
191.
Alvarez O, Mertz P,
Eaglstein. The effect of proline analogue, 1-azetidine -2
carboxyline and on epidermal and dermal wound repair. Plastic
Reconstruc Surg 1982: 69; 284.
|
DONOR
SITE DRESSINGS
Feldman D: Which dressing for
split thickness skin graft donor sites? Ann Plastic Surg 1991:
278-288.
Zapata-Sorvent R, Hanshough
J, et al. Companion of biobrane and scarlet red dressings for
treatment of donor site wounds. Arch Surg 1985: 120; 743.
Feldman D, Rogers A,
Karpanski. A prospective study of comparing biobrane, duodorm and
xeroform for skin graft donor sites. Surg Gynecol Obstet 1991: 173; 1.
EVOLUTION OF BURN CARE
Haynes B. The history of burn
care in the ar and source of burn care. John Boswich, editor. Aspen
Publication, 1987, p 1.
Scarborough J. Roman Medium,
Ithaca, New York, Cornell University Press, 1989.
Rhazes:
Continens, Venice
Scotini, 1556, p 301.
Sonnenburg E. Dis
Verbirennungen und die. Efrierunzen, Stattgast 1915: pg 618.
Ericksen J. On the pathology
of burns. London Medical Gazette 1843: 31, pg 524.
Copeland W. The treatment of
burns in the Medical Record (NY) 1887; 31: 518.
Artz C. Historical aspects of
burn management. Surg Clin N Amerc 1970:50; 6.
Davidson E. Tannic acid in
the treatment of burns. Surg Gynecol obstet 1925: 41; 202.
Aldrich R. The role of
infection in burns: theory and treatment using gentian violet. N Eng J
Med 1933: 208; 249.
Moncrief J. The development
of topical therapy. J Trauma 1971: 11; 988..
|
|
ALLOGRAFT
TISSUE USE
Brown J, Freyer M et al.
Post mortem hemografts as biologic dressings for extensive burns.
Ann Surg 1953: 138; 618.
Hermans M. Clinical
experience with glycerol preserved donor skin treatment in partial
thickness burns. Burns 1989: 15; 57.
Shuck J. The use of
homografts in burn therapy. Surg Clin N Amer 1970: 50; 1325.
May S, Wainwright J.
Variables determining the amount of microbiol contamination on
cadaveric allograft skin used as a biological wound dressing. Burns
1985: 11; 242.
American Association of
tissue banks standards for tissue banking 1996: 354, 18.
Sabella N. Use of fetal
membranes in skin grafting. Med Rec , NY 1913: 83; 478.
Colocho G, Graham W, et al.
Human amniotic membrane as a physiologic wound dressing. Arch Surg
1974: 109; 370.
Pigeon J. Treatment of
second degree burns with amniotic membranes. J Can Med Assoc 1960:
83; 844.
BIOBRANE
Partial
Thickness Burns and Donor Site
Tavis M, Thornton J,
Bartlett R, Woodroof E. A new composite skin substitute prosthesis.
Burns 1980: 31; 552-558.
Frank D, Wachtel T, Frank
N. Comparison of biobrane, procine and human allograft as biologic
dressings for burn wounds. Surg Forum 1980: 31;552-558.
Woodroof E. Biobrane, a
biosynthetic prosthesis. In Wise D (ed), Burn Wound Coverage, CRC
press 1984.
Gerding R, Fratianne R.
Biosynthetic skin substitute vs 1% silver sulfadiazine for treatment
of inpatient partial thickness thermal burns. J Trauma 1988:
28;1265.
Zapata-Sirvent R, et al.
Comparison of biobrane and scarlet red dressings for treatment of
donor site wounds. Arch Surg 1985: 120;743.
Hansbrough
JF,
Zap0ata-Sirvent R, Carrol W, et al: Clinical experience with the use
of biobrane as a dressing for burn wounds. Dialysis Tranplant Burn
1984:2; 37.
Zachary L, Robson M,
Higgens J. The use of topical antibiotics combined with biobrane in
burn wound infections. J Trauma 1982:22; 833.
Klein RL, Rothmann BF and
Marshall R. Biobrane - A useful adjunct in the therapy of outpatient
burns. Journal of Pediatric Surgery 1984: 19;846.
Phillips
LG, Robson MC and
Smith DJ. Et al: Uses and abuses of a biosynthetic dressing for
partial-skin thickness burns. Burns 1989: 15;254.
Lin SD, Chai CY and Lai CS
et al. A mixture of allogeneic and autologous microskin grafting of
rabbit skin wounds with biobrane overlay. Burns 1994: 20;30.
Smith DJ, Jr. Indications
for use of biobrane in wound management. Journal of Burn Care and
Rehabilitation 1995:16; 317.
Rodeheaver
GT, Hartsell L
and Faulkner BS et al. Influence of biobrane construction on
adherence. Journal of Burn Care and Rehabilitation 1995: 16; 321.
Gerding
RL, Emerman CL and
Effron D., et al: Out patient management of partial-thickness burns:
Biobrane versus 1% silver sulfadiazine. Annals of Emergency Medicine
1990: 19;121.
Grisolia GA, Pelli P and
Pinzanti E. et al.: Skin substitutes in the treatment of deep
partial skin thickness burns in children: clinical experience and
long-term results. Burns 1991: 17;52.
Demling
RH. Use of biobrane
in management of scalds. Journal of Burn Care and Rehabilitation
1995: 16;329.
Hansbrough JR, Christine D
and Hasbrough W., et al: The use of biobrane II and specialty
airflow beds (Fluid Air Plus and Kinair) for effective coverage of
extensive posterior donor site wounds. Journal of Burn Care and
Rehabilitation 1994: 15; 137.
Arevalo J., Lorento J. Skin
coverage with biobrane biomaterial for the treatment of patients
with toxic epidermal neurolysis. J Burn Care Rehab 1999:20; 406.
|
PROPERTIES
OF SKIN SUBSTITUTES: AN OVERVIEW
Pruitt B, Levine N.
Characteristics and uses of biologic dressings as skin substitutes.
Arch Surg 1984: 119; 312.
Pruitt B. The evolutionary
development of biologic dressings and skin substitutes. J Burn Care
Rehab 1997: 18; 2.
Chvapel M. Considerations
on manufacturing principles of a synthetic burn dressing.
J Biomed Mat Res 1982: 16;
275.
Madden M, Finkelstein J, et
al: Skin substitutes: Current clinical status. Contemp Surg 1994:
45; 23.
Carns B, Meyer A, et al:
Skin replacements: the biotechnological quest for optimal wound
closure. Arch Surg 1993: 128; 12-16.
Brown R, Smith K, et al:
Strategies for cell engineering in tissue repair. Wound Rep Req
1997: 5; 212.
Bartlett R, Skin
Substitutes. J Trauma 1981: 21; 731.
Bell E. Deterministic
models for tissue engineering. J Cell Engin 1995: 1;28.
Curtis A, Wilkinson C, et
al: Cellular guidance movement and growth: accelerating cell
movement. J Cell Engin 1995: 1;35.
Yannas IV, Burke J, et al:
Design of an artificial skin: basic design principles. J Biomed Matr
Res 1980: 14; 65.
Yannas I, Hansbrough J,
Ehrlich N. What criteria should be used for designing artificial
skin replacements and how well do the current grafting materials
meet these criteria? J Trauma 1984: 24; 29.
Langer R, Vacanti J: Tissue
engineering. Science 1993: 260; 920.
Juliano R, Haskell S:
Signal transduction from extracellular matrix. J Cell Biol 1993:
12;577-580.
Curtis A, Varde M: Control
of cell behavior: topographical factors. J Natl Can Instit1994:
33;15-26.
Gumbiner B. Cell adhesion:
the molecular basis of tissue architecture and morphogenesis. Cell
1996: 84; 345-357.
Putnam AJ, Mooney DJ.
Tissue engineering using synthetic extracellular matrices. Nature
Med 1996: 2;824-826.
Excised Burn
Wounds
Frank DH, Brahme J and Van
de Berg JS.: Decrease in rate of wound contraction with the
temporary skin substitute biobrane. Annals of Plastic Surgery
1984:12; 519.
Frank DH and Bonaldi LC.:
Inhibition of wound contraction: comparison of full-thickness skin
grafts, biobrane, and aspartate membranes. Annals of Plastic Surgery
1985: 14; 103.
TRANSCYTE
Excised Burn
Wounds
Hansbrough
JF, Morgan J,
Greenleaf G, Underwood J: Development of a temporary living skin
replacement composed of human fibroblasts cultured in biobrane, a
synthetic dressing material. Surgery 1994: 115; 633-644.
Hansbrough
JF, Mozingo DW,
Kealey GP, Davis M, Gidner A, Gentzkow GD. Clinical trials of a
biosynthetic temporary skin replacement, Dermagraft-Transitional
covering compared with cryopreserved human cadaver skin for
temporary coverage of excised burn wounds. J Burn Care Rehabil 1997:
18;43-51.
Purdue GF, Hunt JL, Still
JM Jr, Law EJ, Hernson DN, Goldfarb IW, Schiller WR, Hansbrough JF,
Hickerson WK, Himel HN, Kealey GP, Twomey J, Missavage AE, Solem LD,
Davis M, Totoritis M, Gentzkow GD. A multicenter clinical trial of a
biosynthetic skin replacement, Dermagraft-TC, compared with
cryopreserved human cadaver skin for temporary coverage of excised
burn wounds. J Burn Care Rehabil 1997: 18;52-57.
Partial
Thickness Burns
Dare C, Hansbrough J.
Management of partial thickness burns with Dermagraft-TC. J Burn
Care Rehab 1998: 19;172.
Demling R, DeSanti L.
Management of partial thickness facial burns (comparison of topical
antibiotics and bioengineered skin substitutes). J Burn Care Rehab
1999; 25; 256.
|
|
USE OF XENOGRAFTS IN BURNS
Pruitt B, Silvestein P.
Methods of resurfacing denuded skin areas. Transplant Proc 1971: 3;
1537.
Haynes B. The history of burn
care. In Bosivich J, editor, The art and science of burn care.
Rockville, Md. Aspen Publ 1987; 3.
Piccola N. Use of frog skin
as a temporary biologic dressing. Proc Amer Burn Assoc 1992: 24.
Bromberg B, Song J. The use
of pigskin as a temporary skin substitute. Plast Reconstr Surg 1965:
36; 80.
Sneve H. The treatment of
burns and skin grafting. JAMA 1905: 45;1.
Switzer W, Monerief J, et al.
The use of canine heterografts in the therapy of thermal injury. J
Trauma 1966: 391.
Pruitt B, Levine N.
Characteristics and uses of biologic dressings and skin substitute.
Arch Surg 1984: 119; 312.
|
|
